HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation.
about
Advances in epigenetic glioblastoma therapy.Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas.CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1.Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide.The Hippo transducer TAZ promotes cell proliferation and tumor formation of glioblastoma cells through EGFR pathwayLlgl1 prevents metaplastic survival driven by epidermal growth factor dependent migrationOverexpression of FZD7 promotes glioma cell proliferation by upregulating TAZ.MiR-613 suppresses retinoblastoma cell proliferation, invasion, and tumor formation by targeting E2F5.Downregulation of miR-377 Promotes Oral Squamous Cell Carcinoma Growth and Migration by Targeting HDAC9.Overexpression of HDAC9 promotes oral squamous cell carcinoma growth, regulates cell cycle progression, and inhibits apoptosis.The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP.MINA controls proliferation and tumorigenesis of glioblastoma by epigenetically regulating cyclins and CDKs via H3K9me3 demethylation.Cancer-testis Specific Gene OIP5: A Downstream Gene of E2F1 that Promotes Tumorigenesis and Metastasis in Glioblastoma by Stabilizing E2F1 Signalling.
P2860
Q33567030-83506AC1-138D-41FD-818A-3CCEEBCD8E9FQ33737472-CE1FD876-C362-4C4D-A254-E827513CB327Q36281750-E6188E2F-00FF-4A14-BB94-5C1F08B8AE6DQ36893228-369589BD-637C-4401-912C-098C73A87C30Q36977690-1351C140-0DD3-4B09-B11D-28B3611E582AQ37392691-A4EE71CB-8E17-4AF5-9ECB-24AD7AE14B2AQ37641518-F37C8ADB-9DB2-4D40-A967-10076DAE5F2BQ37699166-F224B8A6-E4BC-4C11-885A-9B6EBE44D6F4Q38709864-C303FB6F-1C45-4FFB-93D3-696009953F14Q38713365-8131BBFE-4F1B-4713-BD83-071444C26BFBQ38785012-FE1D9C7F-5AD6-4FF9-8320-F3C5DEBD25A1Q40254224-ABAD4E2D-8779-42E8-B905-A8D929B80DCCQ48682137-4E465C6D-2E27-480A-8AAC-675B84BD273EQ52726122-53DBE877-BE12-443F-90E3-099A47D7D31E
P2860
HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation.
@ast
HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation.
@en
type
label
HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation.
@ast
HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation.
@en
prefLabel
HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation.
@ast
HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation.
@en
P2093
P2860
P356
P1433
P1476
HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation.
@en
P2093
Hongjuan Cui
Jiahua Zou
Yundong Zhang
Zhongfeng Sun
P2860
P304
P356
10.18632/ONCOTARGET.3223
P407
P577
2015-04-01T00:00:00Z